Efficient synthesis of antiviral agent uprifosbuvir enabled by new synthetic methods
Artis Klapars1, John Y L Chung1, John Limanto1
1Department of Process Research and Development, Merck & Co., Inc. Rahway New Jersey 07065 USA artis_klapars@merck.com.
Abstract:
An efficient route to the HCV antiviral agent uprifosbuvir was developed in 5 steps from readily available uridine in 50% overall yield. This concise synthesis was achieved by development of several synthetic methods: (1) complexation-driven selective acyl migration/oxidation; (2) BSA-mediated cyclization to anhydrouridine; (3) hydrochlorination using FeCl3/TMDSO; (4) dynamic stereoselective phosphoramidation using a chiral nucleophilic catalyst. The new route improves the yield of uprifosbuvir 50-fold over the previous manufacturing process and expands the tool set available for synthesis of antiviral nucleotides.
More Related Videos
Related Concept Videos
Viruses with RNA Genomes
Retrovirus Life Cycles


